Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,480,144
Closed -$26.6M 57
2025
Q2
$26.6M Sell
3,480,144
-99,065
-3% -$646K 0.85% 31
2025
Q1
$22.4M Hold
3,579,209
0.72% 34
2024
Q4
$26.2M Hold
3,579,209
0.98% 32
2024
Q3
$41.2M Sell
3,579,209
-600,554
-14% -$7.2M 1.31% 26
2024
Q2
$55.3M Sell
4,179,763
-117,675
-3% -$1.68M 1.65% 23
2024
Q1
$61.5M Hold
4,297,438
1.76% 21
2023
Q4
$46M Buy
+4,297,438
New +$43.8M 1.54% 27

Other funds holding ABVX

Deep Track Capital's ABVX Position: Q3 2025 in Review

Deep Track Capital sold out of Abivax (ABVX) in Q3 2025, closing a stake of 3,480,144 shares — an estimated $26.6M sold.

Deep Track Capital first reported a position in ABVX in Q4 2023 and held it in 7 quarters. The position peaked at $61.5M in Q1 2024. 165 funds tracked by Wall St. Rank hold ABVX as of Q3 2025.

  • Deep Track Capital reported no remaining Abivax position as of Q3 2025 after selling out during the quarter.
  • Deep Track Capital sold 3,480,144 Abivax shares in Q3 2025, an estimated $26.6M.
  • Deep Track Capital first reported a position in Abivax in Q4 2023 and held it in 7 quarters.
  • Deep Track Capital's Abivax position peaked at $61.5M in Q1 2024.
  • 165 funds tracked by Wall St. Rank held Abivax as of Q3 2025.

Based on Deep Track Capital's 13F filing for Q3 2025, filed 14 Nov 2025.